Abstract

Purpose Patients with inflammatory bowel disease (IBD) frequently suffer from venous thromboembolic events, and the risk of thromboembolism increases along with disease activity. This study was conducted to discover novel thrombophilic markers using thromboelastography (TEG) and to evaluate the relation between the predisposing factors and the activity of disease in Chinese patients with Crohn's disease (CD) and ulcerative colitis (UC). Methods Thirty-four patients with CD, 29 patients with UC, and 53 healthy volunteers were enrolled into this study. Blood levels of R, K, α Angle, G, maximal amplitude (MA), and LY30 with TEG were determined. Results Mean values of R, K, α Angle, G, and MA were significantly different in patients with CD and UC compared with the healthy individuals. Patients with active CD had different K, α Angle, G, and MA levels compared with patients in remission (P < 0.05, P < 0.001, P < 0.001, and P < 0.001). Levels of R, α Angle, G, and MA were also significantly different in active UC patients compared with those in remission (P < 0.01, P < 0.001, P < 0.001, and P < 0.001). Except for the G level in the CD group, differences in all TEG levels between healthy individuals and IBD patients in remission were not statistically significant. No statistical differences were observed in LY30 among patients with active phase, patients in remission, and the healthy individuals. Conclusion Thrombophilic defects are common in Chinese patients with IBD, and TEG can be considered a new direction to anticoagulant thromboprophylaxis in IBD.

Highlights

  • Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory systemic disease which primarily affects the bowels and causes extraintestinal manifestations simultaneously [1, 2]

  • R and K levels were statistically lower in patients with CD compared with healthy individuals (P < 0:01, P < 0:05). α Angle, G, and maximal amplitude (MA) were significantly higher in patients with CD compared with healthy individuals (P < 0:001, P < 0:001, and P < 0:001)

  • Mean values of α Angle, G, and MA were significantly higher in patients with UC than in the healthy control group (P < 0:001, P < 0:001, and P < 0:001)

Read more

Summary

Introduction

Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory systemic disease which primarily affects the bowels and causes extraintestinal manifestations simultaneously [1, 2]. The patients with IBD have an approximately 3-fold higher risk of venous thromboembolism (VTE) compared with persons without IBD, and the risk of VTE increases along with disease activity [3, 4]. Several studies using various markers of the coagulation system have revealed the risk of thrombosis in IBD patients, such as protein C, protein S, and antithrombin III [6, 7]. The heterogeneity in the identified studies remains and the precise mechanism of hypercoagulability in IBD is not understood well. TEG is likely to be valuable for appraising coagulation status and the response to anticlotting therapy. TEG has been used in various clinical conditions, such as in pregnant patients, in obstetric patients, Gastroenterology Research and Practice

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call